220 related articles for article (PubMed ID: 30373440)
1. Impact of clinicopathologic factors on survival in patients with sebaceous carcinoma of the eyelid - a population-based analysis.
Lee IJ; Koh JY
Orbit; 2019 Aug; 38(4):261-268. PubMed ID: 30373440
[No Abstract] [Full Text] [Related]
2. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Sharma A; Kashyap S; Chosdol K; Pushker N; Bajaj MS; Bakhshi S
Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
[TBL] [Abstract][Full Text] [Related]
3. Population-based analysis of prognostic indicators in sebaceous carcinoma of the head and neck.
Thomas WW; Fritsch VA; Lentsch EJ
Laryngoscope; 2013 Sep; 123(9):2165-9. PubMed ID: 23670399
[TBL] [Abstract][Full Text] [Related]
4. American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival.
Esmaeli B; Nasser QJ; Cruz H; Fellman M; Warneke CL; Ivan D
Ophthalmology; 2012 May; 119(5):1078-82. PubMed ID: 22330966
[TBL] [Abstract][Full Text] [Related]
5. Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.
Kaliki S; Ayyar A; Dave TV; Ali MJ; Mishra DK; Naik MN
Eye (Lond); 2015 Jul; 29(7):958-63. PubMed ID: 25998946
[TBL] [Abstract][Full Text] [Related]
6. 14-year case series of eyelid sebaceous gland carcinoma in Chinese patients and review of management.
Lam SC; Li EYM; Yuen HKL
Br J Ophthalmol; 2018 Dec; 102(12):1723-1727. PubMed ID: 29459429
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification.
Kaliki S; Gupta A; Ali MH; Ayyar A; Naik MN
Int Ophthalmol; 2016 Oct; 36(5):681-90. PubMed ID: 26830096
[TBL] [Abstract][Full Text] [Related]
8. Sebaceous carcinoma of the eyelids: personal experience with 60 cases.
Shields JA; Demirci H; Marr BP; Eagle RC; Shields CL
Ophthalmology; 2004 Dec; 111(12):2151-7. PubMed ID: 15582067
[TBL] [Abstract][Full Text] [Related]
9. Impact of surgery and adjuvant treatment on the outcome of extraocular sebaceous carcinoma: a systematic review and individual patient's data analysis of 206 cases.
Giridhar P; Kashyap L; Mallick S; Dutt Upadhyay A; Rath GK
Int J Dermatol; 2020 Apr; 59(4):494-505. PubMed ID: 31850516
[TBL] [Abstract][Full Text] [Related]
10. Sebaceous carcinoma of the eyelid: a clinicopathological study.
Zürcher M; Hintschich CR; Garner A; Bunce C; Collin JR
Br J Ophthalmol; 1998 Sep; 82(9):1049-55. PubMed ID: 9893597
[TBL] [Abstract][Full Text] [Related]
11. Eyelid carcinoma: An experience from a tertiary cancer center.
Thiagarajan S; Bahani A; Chaukar D; Dcruz AK
J Cancer Res Ther; 2020 Dec; 16(Supplement):S48-S52. PubMed ID: 33380651
[TBL] [Abstract][Full Text] [Related]
12. Patterns of lymphatic spread and the management of eyelid carcinomas.
Hashimoto K; Yasumatsu R; Toh S; Shiratsuchi H; Yoshida T; Nishiyama K; Yoshikawa H; Nakashima T; Nakagawa T
Auris Nasus Larynx; 2016 Dec; 43(6):666-71. PubMed ID: 26965587
[TBL] [Abstract][Full Text] [Related]
13. Sebaceous cell carcinoma of the ocular adnexa: clinical presentations, histopathology, and outcomes.
Song A; Carter KD; Syed NA; Song J; Nerad JA
Ophthalmic Plast Reconstr Surg; 2008; 24(3):194-200. PubMed ID: 18520834
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of sebaceous carcinoma of the head and neck: implications for lymph node management.
Tryggvason G; Bayon R; Pagedar NA
Head Neck; 2012 Dec; 34(12):1765-8. PubMed ID: 22267270
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, Prognostic Factors, and Treatment of Malignant Submandibular Gland Tumors: A Population-Based Cohort Analysis.
Lee RJ; Tan AP; Tong EL; Satyadev N; Christensen RE
JAMA Otolaryngol Head Neck Surg; 2015 Oct; 141(10):905-12. PubMed ID: 26378411
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients.
Sa HS; Rubin ML; Xu S; Ning J; Tetzlaff M; Sagiv O; Kandl TJ; Esmaeli B
Br J Ophthalmol; 2019 Jul; 103(7):980-984. PubMed ID: 30131380
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa.
Ho VH; Ross MI; Prieto VG; Khaleeq A; Kim S; Esmaeli B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):820-6. PubMed ID: 17709624
[TBL] [Abstract][Full Text] [Related]
18. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
[TBL] [Abstract][Full Text] [Related]
19. Eyelid sebaceous carcinoma: Validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival.
Hsia Y; Yeh CY; Wei YH; Chen LW; Liao SL
Eye (Lond); 2019 Jun; 33(6):887-895. PubMed ID: 31147618
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea.
Choi YJ; Jin HC; Lee MJ; Kim N; Choung HK; Khwarg SI
Jpn J Ophthalmol; 2014 Jul; 58(4):327-33. PubMed ID: 24763914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
